Treatment Patterns, Healthcare Resource Utilization, and Direct Costs Among Patients Initiating Concomitant Use of a Calcitonin Gene-Related Peptide Monoclonal Antibody (CGRP mAb) and Novel Acute Medication in the United States

Treatment Patterns, Healthcare Resource Utilization, and Direct Costs Among Patients Initiating Concomitant Use of a Calcitonin Gene-Related Peptide Monoclonal Antibody (CGRP mAb) and Novel Acute Medication in the United States

Oralee J Varnado,1 Tania Gulati,2 Anthony Wheeler,3 Margaret Hoyt1 1Value Evidence Outcomes – Research & Neuroscience, Indianapolis, IN, USA; 2Value Evidence Outcomes, Real World Evidence, Eli Lilly Services India, Private Limited, Bengaluru, Karnataka, India; 3Value Evidence Outcomes – Outcomes...

Full description

Bibliographic Details
Main Authors: Varnado OJ, Gulati T, Wheeler A, Hoyt M
Format: Article
Language:English
Published: Dove Medical Press 2023-12-01
Series:Patient Preference and Adherence
Subjects:
migraine
cgrp mab
adherence
persistence
cost savings
Online Access:https://www.dovepress.com/treatment-patterns-healthcare-resource-utilization-and-direct-costs-am-peer-reviewed-fulltext-article-PPA

Internet

https://www.dovepress.com/treatment-patterns-healthcare-resource-utilization-and-direct-costs-am-peer-reviewed-fulltext-article-PPA

Similar Items